UAE Gene Editing Technology Databook 2023: Compound Annual Growth of 8.4% Forecast During 2023-2027
June 13, 2023 04:03 ET
|
Research and Markets
Dublin, June 13, 2023 (GLOBE NEWSWIRE) -- The "UAE Gene Editing Technology Databook 2023" has been added to ResearchAndMarkets.com's offering.The UAE gene editing technology market is expected to...
Bacterial and Plasmid Vectors Global Market Report 2023: Increasing Prevalence of Cancer and Infectious Diseases Drives Growth
June 09, 2023 09:38 ET
|
Research and Markets
Dublin, June 09, 2023 (GLOBE NEWSWIRE) -- The "Bacterial And Plasmid Vectors Global Market Report 2023" report has been added to ResearchAndMarkets.com's offering. This report provides...
VaxEquity and CPI Announces Innovate UK Grant to Accelerate Next Generation RNA Vaccines and Therapeutics
June 05, 2023 03:00 ET
|
VaxEquity
CAMBRIDGE, United Kingdom, June 05, 2023 (GLOBE NEWSWIRE) -- VaxEquity, developing transformative RNA vaccines and therapeutics based on its next generation self-amplifying RNA (saRNA) platform, and...
GreenLight Biosciences Enters into Definitive Merger Agreement with Consortium Led by Fall Line Endurance Fund for Go-Private Transaction
May 30, 2023 07:01 ET
|
GreenLight Biosciences
LEXINGTON, Mass., May 30, 2023 (GLOBE NEWSWIRE) -- GreenLight Biosciences Holdings, PBC (NASDAQ: GRNA) (“GreenLight” or the “Company”) today announced that the Company has entered into a definitive...
NGS-Based RNA-sequencing Markets: Sample Preparation, Platforms & Consumables, Services, Data Analysis, De Novo, Epigenetics, Small RNA - Global Forecast to 2027
May 26, 2023 07:23 ET
|
Research and Markets
Dublin, May 26, 2023 (GLOBE NEWSWIRE) -- The "NGS-Based RNA-sequencing Market by Product & Services (Sample Preparation, Platforms & Consumables, Services, Data Analysis), Technology (SBS,...
FDA Grants SiSaf’s Innovative siRNA Therapy SIS-101-ADO Orphan Drug Designation and Rare Pediatric Disease Designation for the Treatment of Autosomal Dominant Osteopetrosis
May 15, 2023 03:00 ET
|
SiSaf Ltd
GUILDFORD, England, May 15, 2023 (GLOBE NEWSWIRE) -- SiSaf Ltd, an RNA delivery and therapeutics company, announces that SIS-101-ADO, its siRNA therapeutic for patients with Autosomal Dominant...
RNA Therapeutics Markets, 2035 - Technical and Financial Perspective on How the Opportunity in this Domain is Likely to Evolve
April 24, 2023 03:33 ET
|
Research and Markets
Dublin, April 24, 2023 (GLOBE NEWSWIRE) -- The "Investor Series: Opportunities in RNA Therapeutics Market" report has been added to ResearchAndMarkets.com's offering. The Investor Series:...
Global NGS-Based RNA-Sequencing Market Report 2023: Growth in Precision Medicine is Fuelling the Sector
April 18, 2023 12:13 ET
|
Research and Markets
Dublin, April 18, 2023 (GLOBE NEWSWIRE) -- The "NGS-Based RNA-Sequencing Global Market Report 2023" report has been added to ResearchAndMarkets.com's offering. This report provides strategists,...
Global Cloning & Mutagenesis Market Report 2023: Increasing Research and Development Activities in Cancer and Other Chronic Disorders Fuels Growth
April 18, 2023 11:58 ET
|
Research and Markets
Dublin, April 18, 2023 (GLOBE NEWSWIRE) -- The "Cloning & Mutagenesis Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F Segmented By Gene Type (Standard v/s...
United Kingdom Cell & Gene Therapy Business and Investment Opportunities Databook - Q1 2023 Update
April 14, 2023 07:33 ET
|
Research and Markets
Dublin, April 14, 2023 (GLOBE NEWSWIRE) -- The "United Kingdom Cell & Gene Therapy Business and Investment Opportunities Databook - Q1 2023 Update" report has been added to ...